Initiating statin therapy in acute cardioembolic stroke may reduce the risk of major vascular events and death compared to no treatment.
Does starting statin therapy during the acute stage of ischemic stroke reduce the risk of major vascular events and death in patients with cardioembolic stroke with no guidance-based indication?
Starting statin therapy in the acute stage of cardioembolic stroke may improve clinical outcomes even in patients without a guideline-based indication.
Absolute Event Rate: 0% vs 0%
Starting statin during the acute stage of ischemic stroke may reduce the risk of major vascular events, vascular death, and all-cause death in patients with cardioembolic stroke with no guidance-based indication for statin.
Park et al. (Fri,) reported a other. Initiating statin therapy in acute cardioembolic stroke may reduce the risk of major vascular events and death compared to no treatment.